- Home
- CNMD vs CERT Comparison
CNMD vs CERT Comparison
Compare CNMD & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- CERT
- Stock Information
- Founded
- CNMD 1970
- CERT 2008
- Country
- CNMD United States
- CERT United States
- Employees
- CNMD N/A
- CERT N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- CNMD Health Care
- CERT Technology
- Exchange
- CNMD Nasdaq
- CERT Nasdaq
- Market Cap
- CNMD 1.7B
- CERT 1.7B
- IPO Year
- CNMD 1987
- CERT 2020
- Fundamental
- Price
- CNMD $54.03
- CERT $10.84
- Analyst Decision
- CNMD Hold
- CERT Buy
- Analyst Count
- CNMD 5
- CERT 7
- Target Price
- CNMD $59.80
- CERT $15.00
- AVG Volume (30 Days)
- CNMD 477.4K
- CERT 1.3M
- Earning Date
- CNMD 10-29-2025
- CERT 08-06-2025
- Dividend Yield
- CNMD 1.49%
- CERT N/A
- EPS Growth
- CNMD 12.82
- CERT N/A
- EPS
- CNMD 3.54
- CERT 0.05
- Revenue
- CNMD $1,326,244,000.00
- CERT $405,755,000.00
- Revenue This Year
- CNMD $6.73
- CERT $12.38
- Revenue Next Year
- CNMD $5.45
- CERT $7.49
- P/E Ratio
- CNMD $15.18
- CERT $218.39
- Revenue Growth
- CNMD 3.94
- CERT 11.61
- 52 Week Low
- CNMD $46.00
- CERT $8.64
- 52 Week High
- CNMD $78.19
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- CNMD 51.16
- CERT 50.18
- Support Level
- CNMD $53.18
- CERT $10.70
- Resistance Level
- CNMD $55.07
- CERT $11.16
- Average True Range (ATR)
- CNMD 1.46
- CERT 0.40
- MACD
- CNMD -0.03
- CERT 0.01
- Stochastic Oscillator
- CNMD 38.47
- CERT 38.26
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.